Remove Medicaid Remove Medicare Remove Pharmaceuticals Remove Public Health services
article thumbnail

340B Court Cases

Healthcare ECONOMIST

The Public Health Service Act ( PHSA ) in 1992, created a program to allow hospitals providing care for underserved communities to be able to access discounted drugs. This case examines how Medicare calculates disproportionate share hospital (DSH) payments to hospitals. Novartis Pharmaceutics v Espinoza.

article thumbnail

Medicare moving to reference pricing?

Healthcare ECONOMIST

“CMS will exclude a drug or biological product that is designated as a drug for only one rare disease or condition under section 526 of the FD&C Act and that is approved for only an indication (or indications) for such disease or condition” Low-spending Medicare drugs. Note that this figure is not inflation indexed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Sheppard Health Law

The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Sheppard Health Law

The expansive legislation includes key health care provisions, including drug pricing reforms, inflationary rebates, Medicare Part D benefit redesign, as well as myriad other updates. Medicare Drug Price Negotiation Program. The Inflation Reduction Act (“IRA”) was signed into law by President Biden on August 16, 2022.

article thumbnail

How a National Emergency Can Bring the Monkeypox Outbreak Under Control

Bill Of Health

Grossly-underfunded and overwhelmed public health agencies are not able to conduct proper surveillance and face vast shortages of testing services, vaccines, and treatment. Persons experiencing symptoms of monkeypox can be effectively treated with known pharmaceuticals, but accessing them, like vaccines, has proven monumental.